HLS — HLS Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for HLS Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	20.6	21.2	20.7	22	17.5
Net Total Accounts Receivable
Net Total Receivables	12.5	11.5	11.2	10.7	7.53
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	45.9	43.8	44.4	44.1	35.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.38	1.57	1.13	0.965	0.997
Net Intangible Assets
Other Long Term Assets
Total Assets	304	276	242	209	160
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	35.6	27.7	31.2	26.7	22.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	135	115	116	111	88.6
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	169	161	125	97.7	71.3
Total Liabilities & Shareholders' Equity	304	276	242	209	160
Total Common Shares Outstanding